GPAM
Glycerol-3-phosphate acyltransferase 1, mitochondrial
Also known as: GPAT1, GPAT1_HUMAN, KIAA1560, MGC26846
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HCL2
- Gene
- GPAM
- Ensembl
- ENSG00000119927
- Chromosome
- 10
- Canonical length
- 828 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes a mitochondrial enzyme which prefers saturated fatty acids as its substrate for the synthesis of glycerolipids. This metabolic pathway's first step is catalyzed by the encoded enzyme. Two forms for this enzyme exist, one in the mitochondria and one in the endoplasmic reticulum. Two alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Oct 2011]
Canonical amino-acid sequenceUniProt
828 residues, UniProt reviewed canonical sequence.
>Q9HCL2|GPAM
1 MDESALTLGT IDVSYLPHSS EYSVGRCKHT SEEWGECGFR PTIFRSATLK WKESLMSRKR
61 PFVGRCCYSC TPQSWDKFFN PSIPSLGLRN VIYINETHTR HRGWLARRLS YVLFIQERDV
121 HKGMFATNVT ENVLNSSRVQ EAIAEVAAEL NPDGSAQQQS KAVNKVKKKA KRILQEMVAT
181 VSPAMIRLTG WVLLKLFNSF FWNIQIHKGQ LEMVKAATET NLPLLFLPVH RSHIDYLLLT
241 FILFCHNIKA PYIASGNNLN IPIFSTLIHK LGGFFIRRRL DETPDGRKDV LYRALLHGHI
301 VELLRQQQFL EIFLEGTRSR SGKTSCARAG LLSVVVDTLS TNVIPDILII PVGISYDRII
361 EGHYNGEQLG KPKKNESLWS VARGVIRMLR KNYGCVRVDF AQPFSLKEYL ESQSQKPVSA
421 LLSLEQALLP AILPSRPSDA ADEGRDTSIN ESRNATDESL RRRLIANLAE HILFTASKSC
481 AIMSTHIVAC LLLYRHRQGI DLSTLVEDFF VMKEEVLARD FDLGFSGNSE DVVMHAIQLL
541 GNCVTITHTS RNDEFFITPS TTVPSVFELN FYSNGVLHVF IMEAIIACSL YAVLNKRGLG
601 GPTSTPPNLI SQEQLVRKAA SLCYLLSNEG TISLPCQTFY QVCHETVGKF IQYGILTVAE
661 HDDQEDISPS LAEQQWDKKL PEPLSWRSDE EDEDSDFGEE QRDCYLKVSQ SKEHQQFITF
721 LQRLLGPLLE AYSSAAIFVH NFSGPVPEPE YLQKLHKYLI TRTERNVAVY AESATYCLVK
781 NAVKMFKDIG VFKETKQKRV SVLELSSTFL PQCNRQKLLE YILSFVVLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPAM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 287 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 287 nTPM
- liver: 135 nTPM
- epididymis: 71 nTPM
- breast: 66 nTPM
- adrenal gland: 32 nTPM
- blood vessel: 26 nTPM
Single-cell type
- adipocytes: 1,999 nCPM
- hepatocytes: 279 nCPM
- retinal pigment epithelial cells: 277 nCPM
- adrenal cortex cells: 263 nCPM
- epididymal principal cells: 174 nCPM
- astrocytes: 122 nCPM
Immune cell
- naive B-cell: 1.1 nTPM
- MAIT T-cell: 0.9 nTPM
- naive CD8 T-cell: 0.9 nTPM
- gdT-cell: 0.7 nTPM
- plasmacytoid DC: 0.6 nTPM
- T-reg: 0.6 nTPM
Brain region
- basal ganglia: 26 nTPM
- midbrain: 24 nTPM
- thalamus: 24 nTPM
- amygdala: 22 nTPM
- cerebral cortex: 18 nTPM
- hypothalamus: 18 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.68
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.37
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 1% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activated T cell proliferation
- activation-induced cell death of T cells
- acyl-CoA metabolic process
- CDP-diacylglycerol biosynthetic process
- defense response to virus
- diacylglycerol biosynthetic process
- fatty acid homeostasis
- fatty acid metabolic process
- glycerophospholipid metabolic process
- negative regulation of activation-induced cell death of T cells
- phosphatidic acid biosynthetic process
- phosphatidylglycerol biosynthetic process
- phospholipid homeostasis
- positive regulation of activated T cell proliferation
- positive regulation of multicellular organism growth
- regulation of cytokine production
- response to glucose
- triglyceride biosynthetic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPAM as an antibody target. Whether an autoantibody or antibody against GPAM could matter depends on whether native GPAM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPAM is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GPAM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...